Karyotype service for porcine cells

Code Description Price Qty
K11 Karyotype service for fixed porcine cells $Quote
K12 Karyotype service for live BSL1 porcine cells $Quote
Request A Quote

Request a quote

Our karyotype service for other species provides G-banding analysis of a minimum of 20 metaphase spreads per sample, delivering a detailed report with the karyotype designation in ISCN nomenclature and at least one publication-quality image. We routinely karyotype cells from a wide range of species including pig (porcine), bovine (cow), canine (dog), non-human primate, chicken (Gallus domesticus), sheep (Ovis aries), goat (Capra hircus), and others on request. This service supports quality control for veterinary cell lines, agricultural breeding programmes, and comparative genomics research. We accept both fixed samples (BSL1 and BSL2, shipped at room temperature) and live cell cultures (BSL1, UK and Europe only). Standard turnaround is 7–10 business days. For a full overview of our karyotyping capabilities, see our karyotype analysis service page 

 

  

 

This service currently has good availability. Please contact us at [email protected] to schedule sample arrival. 

 

Protocols and workflow

 

Biosafety level

We are able to process BSL1 samples only. Fixed samples do not require evidence of screening.

Fixed cell requirements

Please strictly adhere to the following requirements for fixed samples:

  • Samples are shipped at room temperature
  • Fixed samples are stored in a 2 mL screw cap tube
  • Samples are minimum 500 µL in volume
  • Please do not send any samples without booking in advance

If you have any questions, please contact us by email at [email protected]. We will respond within one business day.

Citations

See the full updated list on Google Scholar

Burkard M, Bengtson Nash S, Gambaro G, Whitworth D, and Schirmer K. Lifetime extension of humpback whale skin fibroblasts and their response to lipopolysaccharide (LPS) and a mixture of polychlorinated biphenyls (Aroclor). (2019). Cell Biol Toxicol.

Schöndorf DC, Elschami M, Schieck M, Ercan-Herbst E, Weber C, Riesinger Y, Kalman S, Steinemann D, and Ehrnhoefer DE. Generation of an induced pluripotent stem cell cohort suitable to investigate sporadic Alzheimer's Disease. (2018). Stem Cell Research Jan;34:101351.

Joshi PS, Modur V, Cheng J, Robinson K and Rao K. Characterization of immortalized human mammary epithelial cell line HMEC 2.6. (2017). Tumour biology Oct;39(10):1010428317724283.

Tidball AM, Dang LT, Glenn TW, Kilbane EG, Klarr DJ, Margolis JL, Uhler MD, and Parent JM. Rapid Generation of Human Genetic Loss-of-Function iPSC Lines by Simultaneous Reprogramming and Gene Editing. (2017). Stem Cell Reports 9(3): 725-731.

Ludtmann MHR, Arber C, Bartolome F, de Vicente M, Preza E, Carro E, Houlden H, Gandhi S, Wray S, and Abramov AY. Mutations in valosin-containing protein (VCP) decrease ADP/ATP translocation across the mitochondrial membrane and impair energy metabolism in human neurons. (2017). Journal of Biological Chemistry 292(21): 8907-8917.

Zhang Y, Schmid B, Nielsen TT, Nielsen JE, Clausen C, Hyttel P, Holst B, and Freude KK. Generation of a human induced pluripotent stem cell line via CRISPR-Cas9 mediated integration of a site-specific heterozygous mutation in CHMP2B. (2016). Stem Cell Research 17(1): 148-150.

Chen H, Aksoy I, Gonnot F, Osteil P, Aubry M, Hamela C, Rognard C, Hochard A, Voisin S, Fontaine E, et al. Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency. (2015). Nature Communications 6: 7095.